BamSEC and AlphaSense Join Forces
Learn More

Amneal Pharmaceuticals Inc. – Material Contracts

NASDAQ: AMRX    
Share price (5/22/26): $12.42    
Market cap (5/22/26): $3.962 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 8 pages Restrictive Covenants Agreement
12/34/56
EX-10.1
from 8-K 8 pages Restrictive Covenants Agreement
12/34/56
EX-10.14
from 10-K 12 pages Amneal Pharmaceuticals, Inc. 2018 Incentive Award Plan Performance Restricted Stock Unit Grant Notice
12/34/56
EX-10.4
from 10-Q 17 pages Amneal Pharmaceuticals LLC Severance Plan and Summary Plan Description Introduction
12/34/56
EX-10.3
from 10-Q 2 pages Modification No. 3 to Employment Agreement Entered March 11, 2020
12/34/56
EX-10.2
from 10-Q 2 pages Modification No. 3 to Employment Agreement Entered February 6, 2018
12/34/56
EX-10.1
from 10-Q 2 pages Modification No. 2 to Employment Agreement Entered July 29, 2020
12/34/56
EX-10.1
from 10-Q 18 pages Employment Agreement
12/34/56
EX-10.14
from 10-K 12 pages Amneal Pharmaceuticals, Inc. 2018 Incentive Award Plan Performance Restricted Stock Unit Grant Notice
12/34/56
EX-10.3
from 10-Q 49 pages Material contract
12/34/56
EX-10.2
from 10-Q 49 pages Material contract
12/34/56
EX-10.1
from 10-Q 60 pages Material contract
12/34/56
EX-10.7
from 8-K12B 3 pages Stock Surrender Agreement
12/34/56
EX-10.6
from 8-K12B 55 pages Amneal Pharmaceuticals LLC Fourth Amended and Restated Limited Liability Company Agreement Dated as of November 7, 2023
12/34/56
EX-10.5
from 8-K12B 48 pages Third Amended and Restated Stockholders Agreement Dated as of November 7, 2023 by and Among Amneal Group (As Defined Herein), Amneal Pharmaceuticals LLC, Amneal Intermediate Inc. and Amneal Pharmaceuticals, Inc
12/34/56
EX-10.4
from 8-K12B 5 pages Amendment No. 1 to the Tax Receivable Agreement November 7, 2023
12/34/56
EX-10.3
from 8-K12B 1 page November 7, 2023 Nikita Shah Re: Elimination of Up-C Structure / Employment Agreement Amendment Dear Nikita
12/34/56
EX-10.2
from 8-K12B 1 page November 7, 2023 Anastasios Konidaris Re: Elimination of Up-C Structure / Employment Agreement Amendment Dear Tasos
12/34/56
EX-10.1
from 8-K12B 1 page November 7, 2023 Andrew Boyer Re: Elimination of Up-C Structure / Employment Agreement Amendment Dear Andrew
12/34/56
EX-10.1
from 8-K 7 pages Term Sheet Amneal Pharmaceuticals, Inc
12/34/56